bioAffinity Technologies (BIAF) vs Charles River Laboratories International (CRL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Charles River Laboratories International is the larger company by market cap ($14.54 billion vs $5.5 million), about 2637.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIAF | CRL |
|---|---|---|
| Share price | $4.73 | $301.79 |
| Market cap | $5.51M | $14.54B |
| 1-day change | -16.22% | +1.27% |
| YTD return | — | +51.29% |
| 1-year return | — | +75.32% |
| 5-year return | — | -25.21% |
| Forward P/E | — | 23.62 |
| EPS (TTM) | $-109.35 | $-4.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $4.02B |
| Revenue growth (YoY) | — | -0.85% |
| Net income (latest FY) | — | $-144.34M |
| Operating margin | — | 0.63% |
| Net margin | — | -3.59% |
| 52-week high | $80.70 | $333.30 |
| 52-week low | $4.56 | $146.20 |
| Distance from 52-week high | -94.14% | -9.45% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +1.06% |
| Average volume | 3.73M | 957.45K |
| Shares outstanding | 1.17M | 48.17M |
| Employees | 57 | 18,300 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Commercial Physical & Biological Resarch |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Charles River Laboratories International is about 2637.1 times larger than bioAffinity Technologies by market value ($14.54B vs $5.51M).
About bioAffinity Technologies
BIAF stock →bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 57 employees
About Charles River Laboratories International
CRL stock →Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 18,300 employees
BIAF vs CRL FAQ
Which is bigger, bioAffinity Technologies or Charles River Laboratories International?
Charles River Laboratories International (CRL) is larger, with a market capitalization of $14.54B compared with $5.51M for bioAffinity Technologies (BIAF).
Are bioAffinity Technologies and Charles River Laboratories International in the same industry?
Yes. Both are classified in the Biotechnology: Commercial Physical & Biological Resarch industry within the Health Care sector.